KB
MJN

Kimelman & Baird’s Mead Johnson Nutrition Company MJN Stock Holding History

Kimelman & Baird’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,010
Closed -$1.34M – 126
2017
Q1 		$1.34M Hold
15,010
– – 0.2% 57
2016
Q4 		$1.06M Sell
15,010
-260
-2% -$19.4K 0.18% 59
2016
Q3 		$1.21M Buy
15,270
+1
+0% +$85 0.21% 57
2016
Q2 		$1.39M Buy
15,269
+1
+0% +$85 0.25% 54
2016
Q1 		$1.3M Buy
15,268
+341
+2% +$25.4K 0.24% 55
2015
Q4 		$1.18M Buy
+14,927
New +$1.18M 0.22% 62
2015
Q2 		$1.46M Hold
16,141
– – 0.25% 65
2015
Q1 		$1.62M Hold
16,141
– – 0.3% 62
2014
Q4 		$1.62M Hold
16,141
– – 0.29% 61
2014
Q3 		$1.55M Hold
16,141
– – 0.29% 62
2014
Q2 		$1.5M Buy
16,141
+2,000
+14% +$175K 0.26% 65
2014
Q1 		$1.18M Hold
14,141
– – 0.22% 65
2013
Q4 		$1.18M Hold
14,141
– – 0.23% 67
2013
Q3 		$1.05M Hold
14,141
– – 0.21% 71
2013
Q2 		$1.12M Buy
+14,141
New +$1.13M 0.24% 67

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Kimelman & Baird's MJN Position: Q2 2017 in Review

Kimelman & Baird sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 15,010 shares — an estimated $1.34M sold.

Kimelman & Baird first reported a position in MJN in Q2 2013 and held it in 15 quarters. The position peaked at $1.62M in Q1 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Kimelman & Baird reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Kimelman & Baird sold 15,010 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $1.34M.
  • Kimelman & Baird first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 15 quarters.
  • Kimelman & Baird's Mead Johnson Nutrition Company position peaked at $1.62M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Kimelman & Baird's 13F filing for Q2 2017, filed 22 Aug 2017.